Kennedy's vision for the Department of Health and Human Services includes a significant reliance on artificial intelligence. He advocates for using AI to accelerate drug approval processes, suggesting it could replace traditional animal testing methods. The FDA is already moving towards phasing out some animal testing requirements due to recent legislation. Kennedy's comments reflect a broader trend of skepticism towards expert guidance, promoting AI as a primary decision-making tool in health interventions while raising concerns about the impact on drug testing and vaccine safety monitoring.
Artificial intelligence - arguably, a uselessly vague umbrella term - came up multiple times in a recent interview, highlighting a potential misguided approach to health testing and decisions.
Kennedy implied that AI will fully replace animal testing in the drug approval process, signaling a significant shift in FDA practices shaped by recent legislative changes.
Kennedy's vision for the HHS includes an 'AI revolution', urging viewers to halt trust in experts and instead rely on AI for drug safety and efficacy.
The transition towards AI in drug testing may overlook the critical role of scientific consensus and traditional methodologies that have guided public health decisions.
Collection
[
|
...
]